The head of the European Union’s medicines agency Guido Rasi said on Monday an initial authorization for U.S. pharmaceutical company Gilead’s remdesivir as a Covid-19 treatment could be granted in coming days. “It might be that a conditional market authorization can be issued in the coming days,” Rasi told a hearing in the EU Parliament […] Read more
